Navigation Links
Zinc supplements safe for HIV-infected children

Zinc-deficient children living in communities where they do not receive adequate amounts of zinc from their diet should be given supplements, even if they are HIV-infected, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions.

Previously, it was not known if zinc would speed up HIV disease progression in children by increasing their viral load. Zinc supplementation is known to decrease the frequency of diarrhea and pneumonia in uninfected children. The study is published in the November 26, 2005, issue of The Lancet.

"We set out to look at the safety and impact of zinc supplements in children with HIV. Not only did we learn that zinc is safe for these children, but we also realized that this may be a low-cost intervention to reduce morbidity in HIV-infected children who don't have access to antiretroviral therapy or are not eligible for treatment," said William J. Moss, MD, MPH, senior author of the study and an assistant professor in the Bloomberg School of Public Health's Department of Epidemiology.

The researchers completed a randomized, double-bind, placebo-controlled trial of zinc supplementation at an urban hospital in Pietermaritzburg, South Africa. The 96 children in the study were cared for on a monthly outpatient basis by a team of medical doctors and nurses. Parents were taught how and when to give the 10-mg zinc or placebo tablets to their child every day for six months. The children were seen at the hospital every two weeks for the first month, monthly for five months and, as a final visit, nine months after zinc or placebo supplementation began. At each follow-up visit, parents were asked about illnesses since the last visit. In addition, HIV-1 RNA in plasma and CD4+ T lymphocyte cell counts were measured one month before the study, at the first study visit and three, six and nine months after the start of supplementation.

The study authors found no increase in plasma HI V-1 viral load measurements in the children receiving zinc, meaning that zinc supplementation is safe for HIV-infected children. The CD4+ T lymphocytes and hemoglobin concentrations also were similar between the two study groups. Importantly, HIV-infected children who received zinc supplementation were less likely to get watery diarrhea.

"Programs to increase zinc supplementation in populations with a high prevalence of HIV infection can and should be implemented, and can be done so now that we know zinc does not have an adverse effect on HIV replication. Also, in light of the fact that zinc is known to reduce episodes of diarrhea and pneumonia, zinc supplementation should be used as an adjunct therapy for children with HIV infection," said Moss.


'"/>

Source:Johns Hopkins University Bloomberg School of Public Health


Related biology news :

1. Women cautioned against using herbal supplements
2. Major WHO study concludes calcium supplements can reduce complications during pregnancy
3. HIV-infected adults in Botswana respond positively to ARV therapy public treatment program
4. Low-cost drug gaining favor for use in HIV-infected children in poor countries
5. New study shows benefit of early therapy in HIV-infected infants
6. Meth promotes spread of virus in HIV-infected users
7. $5.1 billion would save 6 million children
8. Genetically engineered animals help in scientific research that may benefit children
9. Bocavirus infection may be associated with pneumonia in Thailand, especially in children
10. Very low birth weight linked to reduced quality of life in pre-school children
11. Embryonic selection of sex avoids conceiving blind children
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/3/2016)... May 3, 2016  Neurotechnology, a provider of ... MegaMatcher Automated Biometric Identification System (ABIS) , a ... projects. MegaMatcher ABIS can process multiple complex biometric ... combination of fingerprint, face or iris biometrics. It ... and MegaMatcher Accelerator , which have ...
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):
(Date:5/6/2016)... ... 06, 2016 , ... Crucial Life Sciences Data Solutions, Inc. ... improves performance of the platform. In particular, Version 4.1 boosts performance for complex ... to be collected on a per patient basis. Clinical Studio has employed a ...
(Date:5/5/2016)... ... May 05, 2016 , ... American Process, Inc. (API) announced ... Patent Nos. 9,322,133 and 9,322,134, to API and its affiliated companies for BioPlus® ... hydrophobic nanocellulose compositions. In addition to these patents and U.S. Patent No. ...
(Date:5/4/2016)... ... 05, 2016 , ... CereScan, the nation’s leader in providing ... National Stroke Awareness Month in May. An infographic created by CereScan will ... CereScan will donate $1 up to a maximum of $3,000 through users who ...
(Date:5/4/2016)... 4, 2016  Bayer today announced that a ... ® (regorafenib) tablets for the treatment of ... its primary endpoint of a statistically significant improvement ... the efficacy and safety of regorafenib in patients ... with sorafenib. The safety and tolerability were generally ...
Breaking Biology Technology: